Namakin Kokab, Hosseini Mahya, Zardast Mahmoud, Mohammadifard Mahyar
Birjand Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences (BUMS), Birjand, Iran.
Department of Pediatric, Student Research Center Birjand University of Medical Sciences, Birjand, Iran.
Pediatr Gastroenterol Hepatol Nutr. 2021 Mar;24(2):187-196. doi: 10.5223/pghn.2021.24.2.187. Epub 2021 Mar 4.
The rising prevalence of childhood obesity in the past decades has caused non-alcoholic fatty liver disease (NAFLD) to become the most common cause of pediatric chronic liver disease worldwide. This study was aimed at determining the effect of vitamin D (Vit D) on ultrasonography and laboratory indices of NAFLD and some blood biochemical indicators in children.
In this interventional study liver ultrasonography was performed in 200 children with overweight and obesity. A 108 had fatty liver among which 101 were randomly divided into two groups of study (n=51) and control (n=50). The study group was treated with Vit D, 50000 U once a week whereas the control group received placebo with the same dose and package, both for 12 weeks. At the end of the intervention lab tests and ultrasound study was performed once again to evaluate the response to treatment.
It was found out that Vit D supplementation improved the fatty liver grade in the study group. The mean changes in hemoglobin (Hb), uric acid, highdensity lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin, albumin and alanine aminotransferase (ALT) was significantly higher in the study group compared to controls (<0.05). After the intervention and means adjustment, a significant difference was obtained in HDL-C, insulin, LDL-C and homeostasis model assessment of insulin resistance (HOMA-IR) between the two groups.
Vit D supplementation in addition to improving the fatty liver grade in ultrasonography and increasing the blood Vit D level, increases the HDL and Hb level besides decreasing uric acid, LDL, HOMA-IR, insulin and ALT levels.
在过去几十年中,儿童肥胖症患病率不断上升,导致非酒精性脂肪性肝病(NAFLD)成为全球儿童慢性肝病的最常见病因。本研究旨在确定维生素D(Vit D)对儿童NAFLD的超声检查和实验室指标以及一些血液生化指标的影响。
在这项干预性研究中,对200名超重和肥胖儿童进行了肝脏超声检查。其中108名患有脂肪肝,将其中101名随机分为研究组(n = 51)和对照组(n = 50)。研究组每周一次接受50000 U的Vit D治疗,而对照组接受相同剂量和包装的安慰剂,为期12周。干预结束时,再次进行实验室检查和超声研究以评估治疗反应。
发现补充Vit D可改善研究组的脂肪肝分级。与对照组相比,研究组血红蛋白(Hb)、尿酸、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、胰岛素、白蛋白和丙氨酸转氨酶(ALT)的平均变化显著更高(<0.05)。干预并进行均值调整后,两组之间的HDL-C、胰岛素、LDL-C和胰岛素抵抗稳态模型评估(HOMA-IR)存在显著差异。
补充Vit D除了可改善超声检查中的脂肪肝分级并提高血液中Vit D水平外,还可提高HDL和Hb水平,同时降低尿酸、LDL、HOMA-IR、胰岛素和ALT水平。